Colonic range of 5‐ASA enemas in healthy individuals, with a comparison of their physical and chemical characteristics. An open, single‐dose, randomized, cross‐over study
Authors:
- 1 July 1997
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 11 (4) , 693-697
Abstract
Background: 5‐Aminosalicylic acid (5‐ASA) is widely used as topical treatment in patients with distal inflammatory bowel disease. The enema spread and retention time are considered to be important factors in the efficacy of this therapeutic agent. Whereas colonic spread is widely investigated in selected patient populations and volunteers, much less attention has been given to the in vitro differences of physical and chemical properties, although they may influence the in vivo characteristics. Methods: Two different brand enemas, Salofalk and Asacol, both containing 2 g mesalazine, were compared with respect to their in vivo and in vitro characteristics. The retrograde spread, maximum distribution and wall adhesion, as well as the retention time of the enemas, was examined by the addition of a technetium tracer dose in 12 healthy volunteers on two separate occasions. In addition, several chemical properties such as pH, viscosity, particle size, dispersion rate, specific surface area and residual volume after application were analysed and compared. Results: With its larger volume and higher viscosity the Asacol preparation reached a substantially larger proportion of the colon and produced a significantly higher retention time in the proximal parts of the large intestine. In addition, more than double the amount of 5‐aminosalicylic acid was not expelled from the semi‐rigid Salofalk enema container after application. With respect to chemical properties it was demonstrated that the Asacol preparation showed a significantly smaller size of micronized 5‐aminosalicylic acid particles, better homogeneity and much less aggregation of the drug. This resulted in an almost threefold higher specific surface area per g active compound. Conclusions: The Asacol enema appears to be superior in several aspects of the galenical formulation. The better dispersion and larger specific surface area, in conjunction with a larger distribution, better bowel wall adherence and retention time in vivo, constitute a clear theoretical and possible clinical advantage.Keywords
This publication has 8 references indexed in Scilit:
- Better quality of therapy with 5-ASA colonic foam in active ulcerative colitisDigestive Diseases and Sciences, 1993
- Optimum dosage of 5-aminosalicylic acid as rectal enemas in patients with active ulcerative colitis.Gut, 1991
- Mechanism of action of 5-aminosalicylic acid and its derivativesClinical Science, 1990
- Mesalazine (5-Aminosalicylic Acid) Suppositories in the Treatment of Ulcerative Proctitis or Distal Proctosigmoiditis: A Randomized Controlled TrialScandinavian Journal of Gastroenterology, 1990
- 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitisGastroenterology, 1987
- 5-Aminosalicylic Acid Enemas in the Maintenance of Remission in Distal Ulcerative Colitis and ProctitisCanadian Journal of Gastroenterology and Hepatology, 1987
- The spreading of foam and solution enemasInternational Journal of Pharmaceutics, 1985
- TREATMENT OF ULCERATIVE COLITIS WITH HIGH-DOSE 5-AMINOSALICYLIC ACID ENEMASThe Lancet, 1981